Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
This study seeks to better predict patient-derived tumor responsiveness to immune checkpoint blockade.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1101059.htm
- Syndication ID: 19540
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:13 PM
- Date Syndication Updated: Tuesday, June 22, 2021 at 09:13 AM
Embed Code Snippet
To get the embed code snippet please Login.
